A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Phase 2
666
about 3.1 years
40–85
32 sites in CA, CO, FL +9
What this study is about
This trial is testing a treatment called verekitug (UPB-101) in people with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD). The goal is to see if this treatment helps improve symptoms and is safe for them.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take Verekitug
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Change in pre-bronchodilator forced expiratory capacity in 1 second (FEV1), Incidence of treatment-emergent adverse events and serious adverse events
Respiratory